Publication

Behavioral, social, and emotional symptom comorbidities and profiles in adolescent survivors of childhood cancer: A report from the childhood cancer survivor study

Downloadable Content

Persistent URL
Last modified
  • 03/06/2025
Type of Material
Authors
    Tara M. Brinkman, St. Jude Children Research HospitalChenghong Li, St. Jude Children Research HospitalKathryn Vannatta, Children's Hospital ColumbusJordan Marchak, Emory UniversityJin-Shei Lai, Northwestern UniversityPinki K. Prasad, Louisiana State UniversityCara Kimberg, St. Jude Children Research HospitalStefanie Vuotto, St. Jude Children Research HospitalChongzhi Di, Fred Hutchinson Cancer Research CenterDeokumar Srivastava, St. Jude Children Research HospitalLeslie L. Robison, St. Jude Children Research HospitalGregory T. Armstrong, St. Jude Children Research HospitalKevin R. Krull, St. Jude Children Research Hospital
Language
  • English
Date
  • 2016-10-01
Publisher
  • American Society of Clinical Oncology
Publication Version
Copyright Statement
  • © 2016 by American Society of Clinical Oncology.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0732-183X
Volume
  • 34
Issue
  • 28
Start Page
  • 3417
End Page
  • 3425
Grant/Funding Information
  • Supported by Grant No. CA55727 from the National Cancer Institute, by Cancer Center Support CORE Grant No. CA21765, and by the American Lebanese Syrian Associated Charities.
Abstract
  • Purpose: In the general population, psychological symptoms frequently co-occur; however, profiles of symptom comorbidities have not been examined among adolescent survivors of childhood cancer. Patients and Methods: Parents of 3,893 5-year survivors of childhood cancer who were treated between 1970 and 1999 and who were assessed in adolescence (age 12 to 17 years) completed the Behavior Problems Index. Age- and sex-standardized z scores were calculated for symptom domains by using the Childhood Cancer Survivor Study sibling cohort. Latent profile analysis identified profiles of comorbid symptoms, and multivariable multinomial logistic regression modeling examined associations between cancer treatment exposures and physical late effects and identified symptom profiles. Odds ratios (ORs) and 95% CIs for latent class membership were estimated and analyses were stratified by cranial radiation therapy (CRT; CRT or no CRT). Results: Four symptoms profiles were identified: no significant symptoms (CRT, 63%; no CRT, 70%); elevated anxiety and/or depression, social withdrawal, and attention problems (internalizing; CRT, 31%; no CRT, 16%); elevated headstrong behavior and attention problems (externalizing; CRT, no observed; no CRT, 9%); and elevated internalizing and externalizing symptoms (global symptoms; CRT, 6%; no CRT, 5%). Treatment with ≥ 30 Gy CRT conferred greater risk of internalizing (OR, 1.7; 95% CI, 1.0 to 2.8) and global symptoms (OR, 3.2; 95% CI, 1.2 to 8.4). Among the no CRT group, corticosteroid treatment was associated with externalizing symptoms (OR, 1.9; 95% CI, 1.2 to 2.8) and ≥ 4.3 g/m 2 intravenous methotrexate exposure was associated with global symptoms (OR, 1.5; 95% CI, 0.9 to 2.4). Treatment late effects, including obesity, cancer-related pain, and sensory impairments, were significantly associated with increased risk of comorbid symptoms. Conclusion: Behavioral, emotional, and social symptoms frequently co-occur in adolescent survivors of childhood cancer and are associated with treatment exposures and physical late effects. Assessment and consideration of symptom profiles are essential for directing appropriate mental health treatment for adolescent survivors.
Author Notes
  • Corresponding author: Tara M. Brinkman, PhD, Department of Epidemiology and Cancer Control, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, MS 735, Memphis, TN 38105; e-mail: tara.brinkman@stjude.org.
Keywords
Research Categories
  • Health Sciences, Public Health
  • Health Sciences, Oncology
  • Health Sciences, Epidemiology

Tools

Relations

In Collection:

Items